07 Nov Core Scientific Announces Fiscal Third Quarter 2024 Results
Fiscal Third Quarter 2024 Highlights Incurred net loss of $455.3 million due primarily to a net $408.5 million non-cash mark-to-market adjustment to our warrants and other contingent value right liabilities required as a result of significant quarte...